D McTavish
Overview
Explore the profile of D McTavish including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
1473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Newton J, Graham J, McLoughlin K, Moore A, McTavish D
J Manag Med
. 2001 Feb;
14(1):37-46.
PMID: 11183997
Describes the findings from the first year of an evaluation of change at a PMS+ site in West Cumbria. The study has used qualitative methods including non-participant observation at the...
2.
McTavish D
Scott Med J
. 2000 Dec;
45(5):155-8.
PMID: 11130303
Management of the health service in Scotland and England, has since its creation, shown both divergence and congruence. In the initial decades in Scotland the executive hospital boards (which contained...
3.
McClellan K, Wiseman L, McTavish D
Drugs
. 1998 Apr;
55(3):415-20; discussion 421-2.
PMID: 9530546
Cerivastatin is a synthetic HMG-CoA reductase inhibitor with high liver selectivity, which lowers plasma cholesterol levels by inhibiting endogenous cholesterol synthesis. In vitro, the affinity of cerivastatin for HMG-CoA reductase...
4.
Wilde M, McTavish D
Drugs
. 1997 Oct;
54(4):597-614.
PMID: 9339963
Insulin lispro, a recombinant insulin analogue, is identical to human insulin except for the transposition of proline and lysine at positions 28 and 29 in the C-terminus of the B...
5.
Adkins J, McTavish D
Drugs
. 1997 Aug;
54(2):331-54.
PMID: 9257086
Salmeterol xinafoate is a selective beta 2-adrenoceptor agonist indicated for the maintenance treatment of adults and children with asthma. When administered as a dry powder or aerosol, salmeterol produces bronchodilation...
6.
Davis R, Coukell A, McTavish D
Drugs
. 1997 Jul;
54(1):103-16.
PMID: 9211084
Fosinopril is the prodrug of the active diacid ACE inhibitor fosinoprilat. In patients with heart failure, fosinopril reduces pulmonary capillary wedge pressure, mean arterial blood pressure, mean right atrial pressure...
7.
Lea A, McTavish D
Drugs
. 1997 May;
53(5):828-47.
PMID: 9129869
Atorvastatin is a synthetic HMG-CoA reductase inhibitor which lowers plasma cholesterol levels by inhibiting endogenous cholesterol synthesis. It also reduces triglyceride levels through an as yet unproven mechanism. Dose-dependent reductions...
8.
Jeal W, Barradell L, McTavish D
Drugs
. 1997 Mar;
53(3):415-34.
PMID: 9074843
Alendronate is an aminobisphosphonate which appears to attenuate, rather than completely inhibiting bone turnover, by suppressing the activity of osteoclasts. Clinical trials have established that 10 mg/day orally administered alendronate...
9.
Haria M, McTavish D
Drugs
. 1997 Feb;
53(2):299-336.
PMID: 9028747
Pravastatin is an HMG-CoA reductase inhibitor which lowers plasma cholesterol levels by inhibiting de novo cholesterol synthesis. Pravastatin produces consistent dose-dependent reductions in both total and low density lipoprotein (LDL)-cholesterol...
10.
Goa K, Barradell L, McTavish D
Pharmacoeconomics
. 1996 Dec;
11(1):89-110.
PMID: 10172918
The Scandinavian Simvastatin Survival Study (4S) has confirmed the link between the cholesterol-reducing effects of simvastatin and improved survival in patients with hypercholesterolaemia and pre-existing coronary heart disease (CHD). Pharmacoeconomic...